Background: GLY-200 is a non-absorbed polymer drug currently in Phase 2 clinical trials for the treatment of T2D. GLY-200 was designed to reversibly enhance the barrier properties of the intestinal mucus lining to non-invasively mimic gastric bypass and duodenal exclusion devices. In view of this mechanism of action, GLY-200 has the potential to interfere with the absorption of orally available drugs. As such, we investigated the effect of GLY-200 on the oral absorption of metformin, an antidiabetic agent commonly used in combination with other glucose-lowering medications.

Methods: Metformin (100 mpk) was administered by oral gavage in saline to male Sprague Dawley rats (6-8 weeks old). GLY-200 (400 mpk) was dosed either simultaneously in the same gavage solution, or prior (1- or 3-hours) to the metformin dose. Blood samples were drawn at 0, 0.25, 0.5, 1, 2, 4, 7, 10, and 24 hours following the metformin dose, and a pharmacokinetic (PK) analysis was performed using a noncompartmental model (Phoenix WinNonlin v. 8.3).

Results: GLY-200 altered the rate but did not meaningfully alter the extent of metformin absorption. The greatest effect was observed when the two drugs were dosed together (Cmax ↓34%; tmax ↑100%; AUC ↑11%). The observed changes may be a result of slowed GI transit with GLY-200 administration.

Conclusions: The oral absorption and PK profile of metformin was not significantly altered when the drug was coadministered with GLY-200 or given 1- or 3-hours after a GLY-200 dose. These results suggest that GLY-200 could be used in combination with metformin, whose pharmacologic action is not dependent on Cmax.


M.Fineman: Employee; Glyscend Inc., Stock/Shareholder; Glyscend Inc. C.Bryant: Employee; Glyscend Inc. T.H.Jozefiak: Employee; Glyscend Inc., Stock/Shareholder; Glycologix, LLC. A.Nimgaonkar: Employee; Glyscend Inc. T.Carlson: Employee; Glyscend Inc.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at